FDA Warns Consumers About High-Lidocaine Topical Pain Relief Products

FDA Warns Consumers About High-Lidocaine Topical Pain Relief Products
The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times
|Updated:
0:00

The U.S. Food and Drug Administration (FDA) has warned the public to avoid using certain over-the-counter topical products marketed to relieve pain before, during, or after specific cosmetic procedures, including microdermabrasion, laser hair removal, tattooing, and piercing.

The agency has issued warning letters to six companies responsible for manufacturing these products, citing violations of federal law due to containing higher concentrations of lidocaine than permitted.

A.C. Dahnke
A.C. Dahnke
Author
A.C. Dahnke is a freelance writer and editor residing in California. She has covered community journalism and health care news for nearly a decade, winning a California Newspaper Publishers Award for her work.